A qualitative study of decision-making on Phase III randomized clinical trial participation in paediatric oncology: Adolescents’ and parents’ perspectives and preferences

2017 ◽  
Vol 74 (1) ◽  
pp. 110-118 ◽  
Author(s):  
Marianne Vie Ingersgaard ◽  
Morten Tulstrup ◽  
Kjeld Schmiegelow ◽  
Hanne Baekgaard Larsen
Keyword(s):  
Clinical Trial ◽  
Decision Making ◽  
Qualitative Study ◽  
Randomized Clinical Trial ◽  
Paediatric Oncology ◽  
Phase Iii ◽  
Trial Participation ◽  
Clinical Trial Participation

scholarly journals Decision-Making Issues for Randomized Clinical Trial Participation among Hispanics

2003 ◽  
Vol 10 (5_suppl) ◽  
pp. 84-86 ◽  
Author(s):  
Lee Ellington ◽  
Stephanie Wahab ◽  
Shadi Sahami ◽  
Rosemary Field ◽  
Kathi Mooney
Keyword(s):  
Clinical Trial ◽  
Decision Making ◽  
Randomized Clinical Trial ◽  
Trial Participation ◽  
Clinical Trial Participation

scholarly journals Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation - a qualitative study

2015 ◽  
Vol 37 (8) ◽  
pp. 1373-1387 ◽  
Author(s):  
Christine Holmberg ◽  
Katie Whitehouse ◽  
Mary Daly ◽  
Worta McCaskill-Stevens
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Breast Cancer Risk ◽  
Qualitative Study ◽  
Cancer Risk ◽  
Trial Participation ◽  
Clinical Trial Participation ◽  
The Future

scholarly journals Cancer Patients' Fears Related to Clinical Trial Participation: A Qualitative Study

2012 ◽  
Vol 27 (2) ◽  
pp. 257-262 ◽  
Author(s):  
Gwendolyn P. Quinn ◽  
Alexis Koskan ◽  
Kristen J. Wells ◽  
Luis E. Gonzalez ◽  
Cathy D. Meade ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Qualitative Study ◽  
Cancer Patients ◽  
Trial Participation ◽  
Clinical Trial Participation

Patterns of decision making about cancer clinical trial participation among the online cancer treatment community: A collaboration between SWOG and NexCura.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. CRA6009-CRA6009
Author(s):  
Joseph M Unger ◽  
Dawn L. Hershman ◽  
Kenda Burg ◽  
Carol Moinpour ◽  
Kathy S. Albain ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Decision Making ◽  
Cancer Treatment ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Trial Participation ◽  
Clinical Trial Participation ◽  
Daily News ◽  
Online Supplement ◽  
Final Text

CRA6009 The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Sunday, June 3, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News

Factors associated with patients' loss to follow-up after finishing randomized clinical trial participation

2004 ◽  
Author(s):  
I STRUSBERG ◽  
A BERTOLI ◽  
M RAMOS ◽  
G FIERRO ◽  
R PIZZOLATO ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Trial Participation ◽  
Clinical Trial Participation ◽  
Loss To Follow Up ◽  
Factors Associated

Decision Making in Cancer Prevention and Control

2018 ◽  
Author(s):  
Erin M. Ellis ◽  
Rebecca A. Ferrer
Keyword(s):  
Clinical Trial ◽  
Decision Making ◽  
Palliative Care ◽  
Cancer Patients ◽  
Trial Participation ◽  
Clinical Trial Participation ◽  
High Stakes ◽  
Life And Death ◽  
Fundamental Knowledge ◽  
And Control

Being diagnosed with cancer introduces the need to make many high-stakes decisions about treatments, clinical trial participation, palliative care, advanced care planning, and (sometimes) end-of-life preferences. These decisions can be intensely emotional themselves, and occur within the affectively laden context of cancer-related issues, such as symptom management, interpersonal concerns, and existential questions about life and death. This chapter outlines how affect/emotion influences several decisions faced by cancer patients, and how emotions are relevant to the interpersonal context in which these decisions occur. Emotion has pervasive and predictable—sometimes deleterious and sometimes advantageous—influences on decision making. Fundamental knowledge regarding how affect influences cancer-related decision making could be leveraged to develop interventions to optimize decisions about treatment, clinical trial participation, and palliative care among cancer patients and survivors, thereby improving cancer-related outcomes.

Sign in / Sign up

Export Citation Format

Share Document